longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Canopy Growth

CGC

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • US President Trump will soon reclassify cannabis. (Axios)

    Wallstreetcn·Apr 22 at 03:50 PM
    ACB+4.13%CGC-1.13%
  • Trump will sign an order to reclassify marijuana

    Wallstreetcn·Dec 18, 2025 at 06:53 PM
    CGC-1.13%
  • Trump may significantly relax cannabis restrictions, cannabis stocks soar

    Wallstreetcn·Dec 13, 2025 at 12:10 AM
    - The White House is preparing to significantly relax restrictions on marijuana, with President Trump expected to sign an executive order to reclassify it as a less regulated substance. - This policy change will allow marijuana businesses to benefit from different tax rules and attract investment, leading to a surge in cannabis stocks, including Tilray Brands and Canopy Growth. - The reclassification from Schedule I to Schedule III is anticipated to be implemented early next year, potentially enabling banks to serve the cannabis industry and positively impacting its growth.
    CGC-1.13%
  • Tilray Brands Inc. rose 40% as media reports suggest that U.S. President Trump is expected to ease restrictions on cannabis

    Wallstreetcn·Dec 12, 2025 at 02:55 PM
    TLRY+2.26%SNDL0.00%
  • Cannabis stocks soared 40% in one day! Trump's reclassification of cannabis danger levels ignites the market

    Wallstreetcn·Aug 11, 2025 at 07:58 PM
    - Trump announced he is considering reclassifying marijuana's danger level, leading to a significant rise in cannabis stocks on Monday. - This potential reclassification could allow cannabis companies to benefit from different tax regulations and attract more investment, with experts noting it could be a "game changer" for the $80 billion market. - While the discussion has bipartisan support, the authority to reclassify lies with the Attorney General, not Trump directly.
    CGC-1.13%
  • U.S. stock market update: Canopy Growth rose 10.48%; Eli Lilly rose 0.66%, with a trading volume of $388 million and a market capitalization of $691.9 billion; Novo Nordisk AS rose 2.79%, with a trading volume of $306 million; Johnson & Johnson rose 1.09%, with a trading volume of $150 million

    Price Alert·Jun 6, 2025 at 02:42 PM
    CGC-1.13%LLY+1.04%